Search Results - "KASPAR, Manuela"
-
1
The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
Published in Cancer research (Chicago, Ill.) (15-11-2007)“…One of the most promising new avenues for the development of more selective and efficacious cancer therapies relies on the antibody-mediated targeted delivery…”
Get full text
Journal Article -
2
Paclitaxel Enhances Therapeutic Efficacy of the F8-IL2 Immunocytokine to EDA-Fibronectin―Positive Metastatic Human Melanoma Xenografts
Published in Cancer research (Chicago, Ill.) (01-04-2012)“…The selective delivery of bioactive agents to tumors reduces toxicity and enhances the efficacy of anticancer therapies. In this study, we show that the…”
Get full text
Journal Article -
3
Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
Published in Clinical cancer research (15-10-2008)“…Purpose: There is an interest in the discovery of biopharmaceuticals, which are well tolerated and which potentiate the action of anthracyclines and taxanes in…”
Get full text
Journal Article -
4
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
Published in Arthritis research & therapy (01-01-2009)“…In this article, we present a comparative immunohistochemical evaluation of four clinical-stage antibodies (L19, F16, G11 and F8) directed against splice…”
Get full text
Journal Article -
5
A Novel, Non-immunogenic Fyn SH3-derived Binding Protein with Tumor Vascular Targeting Properties
Published in The Journal of biological chemistry (02-02-2007)“…The generation of novel binding molecules based on protein frameworks (“scaffolds”) represents an emerging field in protein engineering, with the potential to…”
Get full text
Journal Article -
6
In vivo Imaging of Inflammation- and Tumor-Induced Lymph Node Lymphangiogenesis by Immuno―Positron Emission Tomography
Published in Cancer research (Chicago, Ill.) (01-11-2010)“…Metastasis to regional lymph nodes (LN) is a prognostic indicator for cancer progression. There is a great demand for sensitive and noninvasive methods to…”
Get full text
Journal Article -
7
The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis
Published in Cancer research (Chicago, Ill.) (15-05-2007)“…Tumor-targeting immunocytokines represent a new class of anticancer pharmaceutical agents, which often display a superior therapeutic index compared with the…”
Get full text
Journal Article -
8
Fibronectin as target for tumor therapy
Published in International journal of cancer (15-03-2006)“…During cancer progression, the extracellular matrix (ECM) of the tissue in which the tumor grows is extensively remodeled, both by degradation of preexisting…”
Get full text
Journal Article -
9
The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model
Published in Human reproduction (Oxford) (01-09-2011)“…BACKGROUND Endometriosis is still a highly underdiagnosed disease, and the current medical and surgical treatment of endometriosis is associated with a high…”
Get full text
Journal Article -
10
A high‐affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo‐vasculature in vivo
Published in International journal of cancer (01-06-2008)“…The alternatively spliced extra‐domain B of fibronectin is one of the best characterized markers of tumor angiogenesis. Similarly, the extra‐domain A (EDA),…”
Get full text
Journal Article -
11
Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
Published in Blood (05-03-2009)“…The antibody-mediated delivery of therapeutic agents to sites of angiogenesis is an attractive strategy for anticancer therapy, but is largely unexplored in…”
Get full text
Journal Article -
12
A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
Published in Clinical cancer research (15-12-2011)“…L19-IL2 is an immunocytokine composed of an antibody fragment specific to the EDB domain of fibronectin, a tumor angiogenesis marker, and of human…”
Get full text
Journal Article -
13
The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
Published in European journal of cancer (1990) (01-11-2010)“…Abstract Background L19-IL2, a tumour-targeting immunocytokine composed of the recombinant human antibody fragment L19 (specific to the alternatively-spliced…”
Get full text
Journal Article -
14
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
Published in Arthritis research & therapy (01-01-2007)“…The antibody-mediated targeted delivery of cytokines to sites of disease is a promising avenue for cancer therapy, but it is largely unexplored for the…”
Get full text
Journal Article -
15
Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12
Published in Protein engineering, design and selection (01-08-2010)“…Proinflammatory cytokines have been used for several years in patients with advanced cancer but their administration is typically associated with severe…”
Get full text
Journal Article -
16
A Human mAb Specific to Oncofetal Fibronectin Selectively Targets Chronic Skin Inflammation In Vivo
Published in Journal of investigative dermatology (01-04-2007)“…The antibody-based targeted delivery of bioactive agents to sites of angiogenesis is an attractive therapeutic strategy for cancer treatment, but is largely…”
Get full text
Journal Article -
17
Engineered vascular‐targeting antibody‐interferon‐γ fusion protein for cancer therapy
Published in International journal of cancer (20-08-2005)“…A number of cytokines are either approved drugs or are in advanced clinical trials, yet these biopharmaceuticals do not typically localize efficiently in solid…”
Get full text
Journal Article -
18
The antibody-mediated targeted delivery of interleukin-I0 inhibits endometriosis in a syngeneic mouse model
Published in Human reproduction (Oxford) (2011)Get full text
Journal Article -
19
-
20
A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells
Published in Protein engineering, design and selection (01-03-2009)“…The isolation of mammalian cell lines capable of high-yield expression of recombinant antibodies is typically performed by screening multiple individual clones…”
Get full text
Journal Article